Register entry

Laboratorios Imperiales, S.A. de C.V.

Data as of · How to read this entry

Registered sites
1
Active NDC listings
7
Live patents
0
Countries
1
Base
Mexico
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
Laboratorios Imperiales, S.A. de C.V.Calle 13 Este No. 606 Civac, Jiutepec, Morelos 62578, Mexico (MEX)Active ingredient (API) manufacture1000432951812643138
Catalogue

Drug listings by form and route

7

7 active NDC listings: 7 bulk ingredient. By marketing category: BULK INGREDIENT 7.

Dosage formNDCs
powder7
RouteNDCs
Labeller name on the listingNDCs
laboratorios imperiales, s.a. de c.v.7
Catalogue

Marketed products

7
BrandGeneric nameForm / routeNDC
-BISMUTH CITRATEpowder57465-202BULK INGREDIENT
-BISMUTH OXIDEpowder57465-300BULK INGREDIENT
-BISMUTH SUBCARBONATEpowder57465-150BULK INGREDIENT
-BISMUTH SUBGALLATEpowder57465-201BULK INGREDIENT
-BISMUTH SUBNITRATEpowder57465-151BULK INGREDIENT
-Bismuth Subsalicylatepowder57465-200BULK INGREDIENT
-Bismuth Tribromophenatepowder57465-152BULK INGREDIENT
Neighbours

Registered in the same town

3
Compare

Comparable companies in Mexico

Enquiry

Common questions

Is Laboratorios Imperiales, S.A. de C.V. FDA approved?
Laboratorios Imperiales, S.A. de C.V. holds 1 FDA-registered establishment in Mexico. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Laboratorios Imperiales, S.A. de C.V.'s drugs manufactured?
The FDA register lists Jiutepec. Registered operations: active ingredient (API) manufacture.
What drugs does Laboratorios Imperiales, S.A. de C.V. make?
7 products are listed under Laboratorios Imperiales, S.A. de C.V. in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.